Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD30 antibodies and methods for treating CD30+ cancer

Anti-CD30 antibodies and methods for treating CD30+ cancer

US Patent 11584799 · Granted Feb 21, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD2025
Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD2025
Anti-CD30 antibodies2025
Anti-CD30 antibodies2025
Anti-CD30 antibodies2025
Anti-CD30 antibodies2025
Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage2025
T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy2024
T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy2024
Recombinant PD-L1 peptides and methods of use2024
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies2023
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies2023